Estrogen and progesterone receptor mrna levels in primary breast cancer association with patient survival and other clinical and tumor features (1994)
- Authors:
- USP affiliated authors: BRENTANI, MARIA MITZI - FM ; NAGAI, MARIA APARECIDA - FM
- School: FM
- DOI: 10.1002/ijc.2910590310
- Subject: ONCOLOGIA
- Language: Inglês
- Imprenta:
- Source:
- Título do periódico: International Journal of Cancer
- Volume/Número/Paginação/Ano: v.59, p.351-6, 1994
- Este periódico é de assinatura
- Este artigo NÃO é de acesso aberto
- Cor do Acesso Aberto: closed
-
ABNT
NAGAI, Maria Aparecida; MARQUES, L A; YAMAMOTO, L; FUJIYAMA, C T; BRENTANI, Maria Mitzi. Estrogen and progesterone receptor mrna levels in primary breast cancer association with patient survival and other clinical and tumor features. International Journal of Cancer, New York, v. 59, p. 351-6, 1994. DOI: 10.1002/ijc.2910590310. -
APA
Nagai, M. A., Marques, L. A., Yamamoto, L., Fujiyama, C. T., & Brentani, M. M. (1994). Estrogen and progesterone receptor mrna levels in primary breast cancer association with patient survival and other clinical and tumor features. International Journal of Cancer, 59, 351-6. doi:10.1002/ijc.2910590310 -
NLM
Nagai MA, Marques LA, Yamamoto L, Fujiyama CT, Brentani MM. Estrogen and progesterone receptor mrna levels in primary breast cancer association with patient survival and other clinical and tumor features. International Journal of Cancer. 1994 ;59 351-6. -
Vancouver
Nagai MA, Marques LA, Yamamoto L, Fujiyama CT, Brentani MM. Estrogen and progesterone receptor mrna levels in primary breast cancer association with patient survival and other clinical and tumor features. International Journal of Cancer. 1994 ;59 351-6. - Gene expression profile of estrogen receptor negative breast cancer cells transfected with cDNA for estrogen receptor
- Tumor-associated genes differentially expressed in breast tumors regarding the presence or absence of estrogen and progesterone receptors
- Overexpression of the c-myc proto-oncogene in breast cancer
- A expressão do protooncogene C-MYC na próstata humana é modulada pela ação de androgênios
- Ipsilateral breast cancer recurrence in conservative treatment for locally advanced breast cancer
- Differential gene expression in ostrogen receptor negative breast cancer cells transfected with cDNA for ostrogen receptor
- Diferential gene expression in estrogen receptor negative breast cancer cells transfected with cdna for estrogen receptor
- Overexpression of insulin growth factor 2 (IGF2) and H19 gene and relaxation of imprinting of IGF2 in fibroadenomas of the breast
- C-erb-2 dna amplification and mrna expression in human primary breast tumors and its relationship to other prognostic factors
- Differentially expressed genes er/pr-positive and er/pr-negative primary breast tumors
Informações sobre o DOI: 10.1002/ijc.2910590310 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
